3D Bioprinting Market Overview

Numerous factors are adding to the global 3D bioprinting market growth. These factors, according to the recent Market Research Future report, include growing need for transplantation of organs, rising investment in R&D activities, increasing geriatric population, technological advances to manufacture custom made products, innovations, and developments in 3D bioprinting, and increasing use in cosmetic surgery and drug discovery. 

The 3D Bioprinting Market is expected to register a CAGR of 15.4% to reach USD 5.1 Billion during the forecast period 2022-2030

It is reported that the growing demand for organ transplantation is expected to push the growth of the 3D Bioprinting Market. Also, rising occurrences of organ failure owing to accidents, diseases, and old-age have created a massive gap for the functioning of organs. The emergence of 3D bioprinting can fill-in the gap by producing them on a massive scale. Numerous factors are adding to the global 3D Bioprinting Market Size growth. These factors, according to the recent Market Research Future report, include growing need for transplantation of organs, rising investment in R&D activities, increasing geriatric population, technological advances to manufacture custom made products, innovations, and developments in 3D bioprinting, and increasing use in cosmetic surgery and drug discovery. 

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/869

Key Players

Notable players profiled in the 3D bioprinting market report include FUJIFILM Wako Automation Corporation (U.S.), Nano3D Biosciences Inc. (U.S.), Organovo Holdings Inc. (U.S.), REGENHU Ltd. (Switzerland), Aspect Biosystems Ltd. (Canada), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), EnvisionTEC GmbH (Germany), Stratasys Ltd. (U.S.), Cyfuse Biomedical K.K. (Japan), Poietis (France), and Cellink AB (Sweden). 

Industry News

Feb 2020: UPM has recently launched bioinks, called GrowInk. It has been designed for different 3D bioprinting applications, including regenerative medicine and tissue engineering. Water and nano fibrillar cellulose are the two key components of this bioink. This is integrated for offering a defined matrix that can be mixed directly with cells as well as customized. It will be available in three variants- GrowInk-N, GrowInk-T, and GrowInk-ALG.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869

Market Segmentation

Based on the segment, the global 3D bioprinting market has been segmented based on material, end user, technology, and application. 

By technology, the global 3D bioprinting market has been segmented into inkjet 3D bioprinting, microextrusion bioprinting, magnetic 3D bioprinting, and laser-assisted bioprinting. Among these, microextrusion bioprinting will lead the market during the forecast period for its extensive applications in bioprinting. 

By material, the global 3D bioprinting market has been segmented into hydrogels, living cells, and extracellular matrices. Among these, living cells will have the largest share in the market during the forecast period. 

By applications, the market has been segmented into research and clinical applications. Among these, research applications will dominate the market during the forecast period for its extensive application in 3D cell culture and regenerative medicine. 

By end users, the global 3D bioprintingmarket has been segmented into pharmaceutical & biotechnology companies and research organizations & academic institutes. Among these, pharmaceutical & biotechnology companies will hold the largest share in the market during the forecast period. 

Regional Analysis

By region, the global 3D bioprinting market has been segmented based on the following regions- the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Among these, the Americas will dominate the 3D bioprinting market over the forecast period and is likely to touch USD 689.91 million by the end of 2023. Factors propelling market growth in this region comprise the creation of 3D printed pills, which are custom made as per an individuals age and weight, presence of well-established healthcare infrastructure, burgeoning demand for organs, and huge investments in the research and development activities. 

In the Asia Pacific region, the global 3D bioprinting market will grow at a quick pace. It is likely to grow at a 27.25% CAGR and touch USD 507.18 million over the forecast period. Factors propelling market growth in this region comprise huge funds from the government to accelerate the pace of the 3D printing technology, developments and innovations in the healthcare sector, and plentiful opportunities. 

In Europe, the global 3D bioprinting market will have a remarkable growth during the forecast period and is likely to touch USD 649.91 million by the end of 2023. Factors propelling market growth in the region comprise agreements between industry players, rising cases of cosmetic surgery, and increasing emphasis on health & wellness. 

In the MEA, the global 3D bioprinting market will have a slow growth during the forecast period. 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com